Clinical trial
Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of…
NCT00385450 · Mayo Clinic, Other · Terminated
Key facts
| NCT number | NCT00385450 |
|---|---|
| Title | Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor |
| Official title | Cardiopulmonary Bypass-Induced Lymphocytopenia and the Potential Effects of Protease Inhibitor in the Perioperative Period |
| Lead sponsor | Mayo Clinic, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Cardiopulmonary Bypass |
| Intervention type | Drug |
| Interventions | Nelfinavir/placebo |
| Enrollment | 41 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Oct 9, 2006 |
| Last update posted | Apr 28, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: